about
Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem CellsBiology of Bone Tissue: Structure, Function, and Factors That Influence Bone CellsPathobiology of Paget's Disease of BoneUnderstanding cell signalling systems: paving the way for new therapiesBone cell communication factors and SemaphorinsNeuropilins lock secreted semaphorins onto plexins in a ternary signaling complexStructural Basis for Autoinhibition of the Guanine Nucleotide Exchange Factor FARP2Sanguinarine protects against ovariectomy‑induced osteoporosis in miceA Memory of Early Life Physical Activity Is Retained in Bone Marrow of Male Rats Fed a High-Fat Diet.The transcriptional specificity of NF-κB dimers is coded within the κB DNA response elementsBiology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.Soluble guanylate cyclase as a novel treatment target for osteoporosis.Effect of (-)-epigallocatechin-3-gallate in preventing bone loss in ovariectomized rats and possible mechanisms.Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategyPrevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4dProgranulin and a five transmembrane domain-containing receptor-like gene are the key components in receptor activator of nuclear factor κB (RANK)-dependent formation of multinucleated osteoclastsGlycosylation of immunoglobulin G determines osteoclast differentiation and bone lossBreast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro.Semaphorin3a promotes advanced diabetic nephropathyEndocytic Adaptor Protein Tollip Inhibits Canonical Wnt Signaling.Periosteum Metabolism and Nerve Fiber Positioning Depend on Interactions between Osteoblasts and Peripheral Innervation in Rat Mandible.Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor αSemaphorin 4D Promotes Skeletal Metastasis in Breast CancerStructural mechanisms of plexin signalingAlk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch.A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signalingStructure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies.Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.Stimulation of Osteogenesis in Bone Defects Implanted with Biodegradable Hydroxyapatite Composed of Rod-Shaped Particles under Mechanical Unloading.Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiationSemaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction.New roles of osteoblasts involved in osteoclast differentiation.Bone marrow mesenchymal stem cells: fat on and blast off by FGF21Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's diseaseIL-17-producing γδ T cells enhance bone regeneration.Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclastsNaringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.
P2860
Q26746170-C34129A0-91BA-409E-AFF0-C2EA9794CFCBQ26801599-34818815-6BC4-4A68-9046-C3824D31A1DEQ26824476-3FB5896F-75C9-429F-A813-FA187C0C7C52Q26825018-4FF4BC4F-C8F7-4190-B116-752E1F1992C8Q27023494-1AD36EC2-EBB2-4BAE-A159-C980B30BC872Q27674760-9FA97A1B-2CEE-4DD1-A376-4468A9CDFCD1Q27676119-74FFEBE3-2E97-4428-9ABC-32193EC3F3BCQ33828107-1708512A-F117-408F-B871-84819552C8FEQ33881870-B5AE1152-58C9-4D8B-8A5A-9C8B6142B134Q34206952-AA349573-2564-4ABE-87B0-BCE38DCDA36CQ34366449-70637072-823B-47A3-B343-DDBE3382DDF9Q34486033-37263003-A62F-4ADE-AC91-66ACC8EFD2EAQ34551206-7D60E637-379E-453A-9A19-D26F8EA1537DQ34551704-DFC460D1-9F3B-4306-83E8-20447AEAEEE0Q34769905-FB05C24B-5555-4B9F-AF31-ECB4B2DABF7CQ34902134-F4A89950-C1BF-497A-9A80-F77FEF4A55AEQ34950479-7D2511CA-3F38-42AA-BFA5-B4FF338E2AF3Q35002815-9D6B6CB8-3CFC-4373-9FD1-ACC62EFE40EEQ35311994-7A2D12CB-FA4E-4A6D-87A0-BB85C6CA7FCEQ35406039-E854D28F-0396-401C-BB8A-DA0C45E9500FQ35532272-DF013F75-85BA-4821-B1D2-4C3BD0A34CB6Q35674356-0E7A0E7A-F6D1-4371-B388-CD3DDCD73B5BQ35824158-1611DA00-A384-41D7-9E82-869ADA5E7EF4Q35892522-36814B3D-A727-4FF4-B38E-4D7E91214A24Q35933921-51FE0ABF-2A54-4C83-AD8E-EFF566958510Q35958062-C8B4B1F6-A057-4767-9417-0BCC97F0A1B6Q36018663-4E5D5634-89CC-4708-B0F6-51331FEE33F4Q36029858-CE00F219-A200-4823-B99F-124D52196F8FQ36040189-C0516201-B2CD-4144-9A20-3433F5D5802BQ36040583-4F885BD6-32C1-4399-9307-D0CB6E5EAE1AQ36221704-6642FDB9-18F3-4AE0-A9E6-5B75230D708BQ36395303-242612D5-5181-45B1-AFFF-3E8EAF788410Q36399152-8DEF4909-9D6D-4031-A721-0D64F039CBA1Q36480735-99208F13-5CE1-4EFC-8A8F-59C91913F6BFQ36539657-2A8D282C-9F03-4FD7-8E09-D0F1B2E76C6AQ36597639-5BF50A2B-46E1-4076-8E8B-CB40A9677A6BQ36618526-365E6AAC-03F0-4F53-90CE-73470E600E08Q36690217-C0B72EC3-6AF9-4F96-87CC-D4D7F40B7968Q36733053-BA158D8F-0A59-4449-92B1-AF6EC8FDB88CQ36830353-57ED7F7F-D61A-4150-844A-586CB162E82D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Osteoprotection by semaphorin 3A.
@en
type
label
Osteoprotection by semaphorin 3A.
@en
prefLabel
Osteoprotection by semaphorin 3A.
@en
P2093
P921
P356
P1433
P1476
Osteoprotection by semaphorin 3A.
@en
P2093
Atsushi Kumanogoh
Hiroshi Takayanagi
Masahiko Taniguchi
Mikihito Hayashi
Tatsuhiko Kodama
Tomoki Nakashima
P2888
P356
10.1038/NATURE11000
P407
P577
2012-05-01T00:00:00Z
P5875
P6179
1029980310